Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines

Dong Hyeon Lee, Kyusang Park, Indeok Kong, Jun Woo Kim, Bok Ghee Han

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Epstein-Barr virus (EBV) infection immortalizes primary B cells in vitro and generates lymphoblastoid cell lines (LCLs), which are used for several purposes in immunological and genetic studies. Purinergic receptors, consisting of P2X and P2Y, are activated by extracellular nucleotides in most tissues and exert various physiological effects. In B cells, especially EBV-induced LCLs, their expression and function have not been well studied. We investigated the expression of P2 receptors on primary human B cells and LCLs using the quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method for revealing the gene expression profile of the P2 receptor subtypes and their changes during transformation. Results: The mRNA transcripts of most P2 receptors were detected in primary B cells; the expression of P2X3 and P2X7 receptors was the lowest of all the P2 receptors. By contrast, LCLs expressed several dominant P2 receptors - P2X4, P2X5, and P2Y11 - in amounts similar to those seen in B cells infected with EBV for 2 weeks. The amount of most P2 subtypes in LCLs or EBV-infected B cells was lower than in normal B cells. However, the amount of P2X7, receptor expressed in LCLs was higher. Protein expression was studied using Western blotting to confirm the mRNA findings for P2X1, P2X4, P2X7, P2Y1, and P2Y11 receptors. ATP increased the intracellular free Ca2+ concentration ([Ca2+]1) by enhancing the Ca2+ influx in both B cells and LCLs in a dose-dependent manner. Conclusion: These findings describe P2 receptor expression profiles and the effects of purinergic stimuli on B cells and suggest some plasticity in the expression of the P2 receptor phenotype. This may help explain the nature and effect of P2 receptors on B cells and their role in altering the characteristics of LCLs.

Original languageEnglish
Article number22
JournalBMC Immunology
Volume7
DOIs
Publication statusPublished - 2006 Sep 14

Fingerprint

Transformed Cell Line
Human Herpesvirus 4
B-Lymphocytes
Cell Line
Purinergic P2X7 Receptors
Purinergic P2Y Receptors
Purinergic P2X4 Receptors
Purinergic P2X Receptors
Purinergic P2X3 Receptors
Purinergic P2Y1 Receptors
Messenger RNA
Epstein-Barr Virus Infections
Reverse Transcriptase Polymerase Chain Reaction
Transcriptome
Nucleotides
Adenosine Triphosphate
Western Blotting
Phenotype

All Science Journal Classification (ASJC) codes

  • Immunology

Cite this

@article{8e63ac7bb9e843f6888587083c79a951,
title = "Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines",
abstract = "Background: Epstein-Barr virus (EBV) infection immortalizes primary B cells in vitro and generates lymphoblastoid cell lines (LCLs), which are used for several purposes in immunological and genetic studies. Purinergic receptors, consisting of P2X and P2Y, are activated by extracellular nucleotides in most tissues and exert various physiological effects. In B cells, especially EBV-induced LCLs, their expression and function have not been well studied. We investigated the expression of P2 receptors on primary human B cells and LCLs using the quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method for revealing the gene expression profile of the P2 receptor subtypes and their changes during transformation. Results: The mRNA transcripts of most P2 receptors were detected in primary B cells; the expression of P2X3 and P2X7 receptors was the lowest of all the P2 receptors. By contrast, LCLs expressed several dominant P2 receptors - P2X4, P2X5, and P2Y11 - in amounts similar to those seen in B cells infected with EBV for 2 weeks. The amount of most P2 subtypes in LCLs or EBV-infected B cells was lower than in normal B cells. However, the amount of P2X7, receptor expressed in LCLs was higher. Protein expression was studied using Western blotting to confirm the mRNA findings for P2X1, P2X4, P2X7, P2Y1, and P2Y11 receptors. ATP increased the intracellular free Ca2+ concentration ([Ca2+]1) by enhancing the Ca2+ influx in both B cells and LCLs in a dose-dependent manner. Conclusion: These findings describe P2 receptor expression profiles and the effects of purinergic stimuli on B cells and suggest some plasticity in the expression of the P2 receptor phenotype. This may help explain the nature and effect of P2 receptors on B cells and their role in altering the characteristics of LCLs.",
author = "Lee, {Dong Hyeon} and Kyusang Park and Indeok Kong and Kim, {Jun Woo} and Han, {Bok Ghee}",
year = "2006",
month = "9",
day = "14",
doi = "10.1186/1471-2172-7-22",
language = "English",
volume = "7",
journal = "BMC Immunology",
issn = "1471-2172",
publisher = "BioMed Central",

}

Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. / Lee, Dong Hyeon; Park, Kyusang; Kong, Indeok; Kim, Jun Woo; Han, Bok Ghee.

In: BMC Immunology, Vol. 7, 22, 14.09.2006.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines

AU - Lee, Dong Hyeon

AU - Park, Kyusang

AU - Kong, Indeok

AU - Kim, Jun Woo

AU - Han, Bok Ghee

PY - 2006/9/14

Y1 - 2006/9/14

N2 - Background: Epstein-Barr virus (EBV) infection immortalizes primary B cells in vitro and generates lymphoblastoid cell lines (LCLs), which are used for several purposes in immunological and genetic studies. Purinergic receptors, consisting of P2X and P2Y, are activated by extracellular nucleotides in most tissues and exert various physiological effects. In B cells, especially EBV-induced LCLs, their expression and function have not been well studied. We investigated the expression of P2 receptors on primary human B cells and LCLs using the quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method for revealing the gene expression profile of the P2 receptor subtypes and their changes during transformation. Results: The mRNA transcripts of most P2 receptors were detected in primary B cells; the expression of P2X3 and P2X7 receptors was the lowest of all the P2 receptors. By contrast, LCLs expressed several dominant P2 receptors - P2X4, P2X5, and P2Y11 - in amounts similar to those seen in B cells infected with EBV for 2 weeks. The amount of most P2 subtypes in LCLs or EBV-infected B cells was lower than in normal B cells. However, the amount of P2X7, receptor expressed in LCLs was higher. Protein expression was studied using Western blotting to confirm the mRNA findings for P2X1, P2X4, P2X7, P2Y1, and P2Y11 receptors. ATP increased the intracellular free Ca2+ concentration ([Ca2+]1) by enhancing the Ca2+ influx in both B cells and LCLs in a dose-dependent manner. Conclusion: These findings describe P2 receptor expression profiles and the effects of purinergic stimuli on B cells and suggest some plasticity in the expression of the P2 receptor phenotype. This may help explain the nature and effect of P2 receptors on B cells and their role in altering the characteristics of LCLs.

AB - Background: Epstein-Barr virus (EBV) infection immortalizes primary B cells in vitro and generates lymphoblastoid cell lines (LCLs), which are used for several purposes in immunological and genetic studies. Purinergic receptors, consisting of P2X and P2Y, are activated by extracellular nucleotides in most tissues and exert various physiological effects. In B cells, especially EBV-induced LCLs, their expression and function have not been well studied. We investigated the expression of P2 receptors on primary human B cells and LCLs using the quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method for revealing the gene expression profile of the P2 receptor subtypes and their changes during transformation. Results: The mRNA transcripts of most P2 receptors were detected in primary B cells; the expression of P2X3 and P2X7 receptors was the lowest of all the P2 receptors. By contrast, LCLs expressed several dominant P2 receptors - P2X4, P2X5, and P2Y11 - in amounts similar to those seen in B cells infected with EBV for 2 weeks. The amount of most P2 subtypes in LCLs or EBV-infected B cells was lower than in normal B cells. However, the amount of P2X7, receptor expressed in LCLs was higher. Protein expression was studied using Western blotting to confirm the mRNA findings for P2X1, P2X4, P2X7, P2Y1, and P2Y11 receptors. ATP increased the intracellular free Ca2+ concentration ([Ca2+]1) by enhancing the Ca2+ influx in both B cells and LCLs in a dose-dependent manner. Conclusion: These findings describe P2 receptor expression profiles and the effects of purinergic stimuli on B cells and suggest some plasticity in the expression of the P2 receptor phenotype. This may help explain the nature and effect of P2 receptors on B cells and their role in altering the characteristics of LCLs.

UR - http://www.scopus.com/inward/record.url?scp=33750209397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750209397&partnerID=8YFLogxK

U2 - 10.1186/1471-2172-7-22

DO - 10.1186/1471-2172-7-22

M3 - Article

VL - 7

JO - BMC Immunology

JF - BMC Immunology

SN - 1471-2172

M1 - 22

ER -